7/7/2014 10:05:53 AM
BOSTON--(BUSINESS WIRE)--Human Metabolome Technologies, Inc. (HMT), the leading developer of capillary electrophoresis mass spectrometry (CE-MS) based metabolomics, has been recognized by the National Cancer Center’s Office of Science and Technology Resources (OSTR) as a preferred vendor of metabolomic services. Under this program, new technology costs are subsidized by the OSTR in an effort to advance cancer research for NCI's Center for Cancer Research (CCR) investigators.
Help employers find you! Check out all the jobs and post your resume.
comments powered by